# Protagenic Therapeutics, Inc.\\new: Form 8-K, filed Apr 7, 2026

- Company: [Protagenic Therapeutics, Inc.\\new](/companies/ptix.md) (CIK 1022899)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 6, 2026, 19:13 ET
- Period: 2026-03-31
- Accession: 0001493152-26-015365
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1022899/000149315226015365/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1022899/000149315226015365/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1022899/000149315226015365/form8-k.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-015365. Last ingested by Listed: Nov 6, 2026, 14:34 ET. No prices; not investment advice.